Trudeau: Virtual Health Care and Antibody Research to Receive More Than $240M

In a Sunday announcement, Canadian Prime Minister announced the federal government will spend more than $240 million to make it easier for mental health care and other medical services to take place online. Trudeau told media that virtual care is for when patients don’t need to see a doctor in person and hopes the investment can let hospital emergency rooms focus on patients who need to be there.

The PM also announced the government will create a corona-virus supply council to procure personal protective equipment for Canadians as the country prepares to open back up. The new council will be tasked with finding innovative solutions to ensure the country will have vital supplies necessary for the reopening.

This investment will be used to create digital platforms and applications, improve access to virtual mental health support, and expand capacity to deliver health care virtually; including projects to reach vulnerable Canadians.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

So far the lump sum will give more than $175 million to AbCellera, a Vancouver-based company claiming to have isolated hundreds of antibodies that could be used in a potential COVID-19 vaccine. Based on the announcement, it leaves us with speculation that some of the public operators who may receive funding include CloudMD (CSE: $DOC), Telus (TSE: T), Well Health (TSE:WELL) and Loblaw (TSE: L); all of which provide some level of online care. The DeepDive covered this area as being one of the hottest spaces for small caps in Canada back in November and launched coverage on CloudMD; a stock which has nearly doubled over the last 2 months.

Although it is unknown which companies will be granted funding from the federal government; the announcement shows further industry tailwinds for all virtual care providers.


FULL DISCLOSURE: The author does not own any of the securities mentioned above, with the exception of Premier Health Group who is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Premier Group on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

2 Responses

  1. I think we all thought this was another Vancouver special. Six month later they are announcing real deals, adding real board members, massive tailwinds…… Count DOC.cn as a real COVID play.

  2. Will be a disaster for the economy – an accelerated move to online services means trimming fat. Means less jobs. CloudMD – DOC, actually seems like a solid investment here.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Meghan Markle’s Half-Brother Submitted Evidence Against Their Father, But Now Faces Philippine Police Scrutiny

Related News

Internet Of Things Appoints New CEO, Announces New Product Verticals

Internet of Things Inc (TSXV: ITT) this morning announced a shakeup to its management team...

Friday, April 24, 2020, 08:31:02 AM

UN Suggests at Least $1 Trillion in Debt Forgiveness Needed for Developing Countries Amid Pandemic

The United Nations recently issued a statement regarding the fight against COVID-19 in developing countries....

Monday, April 27, 2020, 11:05:18 PM

US Coronavirus Cases Surpass 6 Million, Some Cities Waiting for Vaccine Before Lifting Restrictions

Many states across the US have been eagerly lifting restrictions and lockdown measures in a...

Tuesday, September 1, 2020, 11:10:56 AM

Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials

Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3...

Friday, August 14, 2020, 08:50:35 AM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM